"Maximize complement-targeting in the pan-disease setting" The 5th Complement-based Drug Development Summit returns as the definitive industry-dedicated forum, bringing you the latest preclinical, ..
translational and clinical developments on how to maximize complement-targeting in the pan-disease setting. New for this year, you’ll have two parallel tracks of learning on the intricacies of complement signaling, pipeline progress updates on diverse complement-targeted drug modalities, exploring how to leverage complement proteins in precision-medicine and expand the clinical utility of complement inhibitors across rare diseases, as well as ophthalmic, neurological, cancer and autoimmune settings. Brought direct to your home office with a jam-packed agenda and online virtual networking opportunities, this summit will delve into the fundamental biology of the complement system to identify novel drug targets and help you to clinically validate and accelerate your complement inhibitor through the clinic.
25+ Expert Speakers
Two parallel tracks of content
Uniting industry leaders from Alexion, Apellis, Annexon & more!